Dato Capital
Menu
Home Help Pricing Contact us Español
Log In
New User
Dato Capital United Kingdom

Novator Pharma LLP, United Kingdom

Reports

Includes
  • latest filed accounts (original document), financial statement with balance sheet, assets, etc... (year ending Oct 23, 2013)
  • shareholder details and share percentages
  • original incorporation documents
  • complete list of titles of filed documents
  • full registry information with list of directors and secretaries, addresses and available company phone numbers

Financials

Details

Company type Limited Liability Partnership, Active
Company Number OC365419
Record last updated Tuesday, March 28, 2023 2:57:47 PM UTC
Official Address 8 Shepherd Market 21 Office West End
There are 526 companies registered at this street
Postal Code W1J7JY

Charts

Visits

NOVATOR PHARMA LLP (United Kingdom) Page visits 2024

Searches

NOVATOR PHARMA LLP (United Kingdom) Searches 2024

Directors

Document Type Publication date Download link
Registry Aug 29, 2022 Appointment of a woman Appointment of a woman
Registry Aug 29, 2022 Resignation of one Individual Or Entity With More Than 75% Of Voting Rights In An LLp, one Individual Or Entity With 50-75% Of Voting Rights In An LLp, one Individual Or Entity With Right To Share More Than 75% Surplus Assets In An LLp, one Individual Or Entity With Right To Appoint And Remove Members Of An LLp and one Individual Or Entity With Right To Share 50-75% Surplus Assets In An LLp Resignation of one Individual Or Entity With More Than 75% Of Voting Rights In An LLp, one Individual Or Entity With 50-75% Of Voting Rights In An LLp, one Individual Or Entity With Right To Share More Than 75% Surplus Assets In An LLp, one Individual Or Entity With Right To Appoint And Remove Members Of An LLp and one Individual Or Entity With Right To Share 50-75% Surplus Assets In An LLp
Financials Oct 11, 2017 Annual accounts Annual accounts
Registry Jun 29, 2017 Confirmation statement Confirmation statement
Registry Jun 29, 2017 Persons with significant control Persons with significant control
Financials Jan 9, 2017 Annual accounts Annual accounts
Registry Jun 15, 2016 Annual return Annual return
Registry Apr 6, 2016 Appointment of a man as Individual Or Entity With Right To Share More Than 75% Surplus Assets In An Llp, Individual Or Entity With Right To Appoint And Remove Members Of An Llp and Individual Or Entity With More Than 75% Of Voting Rights In An Llp Appointment of a man as Individual Or Entity With Right To Share More Than 75% Surplus Assets In An Llp, Individual Or Entity With Right To Appoint And Remove Members Of An Llp and Individual Or Entity With More Than 75% Of Voting Rights In An Llp
Financials Dec 1, 2015 Annual accounts Annual accounts
Registry Jul 28, 2015 Annual return Annual return
Financials Oct 30, 2014 Annual accounts Annual accounts
Registry Jul 8, 2014 Annual return Annual return
Financials Oct 23, 2013 Annual accounts Annual accounts
Registry Jul 8, 2013 Annual return of a limited liability partnership Annual return of a limited liability partnership
Financials Sep 24, 2012 Annual accounts Annual accounts
Registry Aug 16, 2012 Annual return of a limited liability partnership Annual return of a limited liability partnership
Registry Jun 10, 2011 Four appointments: 2 women and 2 men Four appointments: 2 women and 2 men

Companies with similar name

Back to Top
Dato Capital
About Us Privacy Policy and GDPRGeneral Cookie PolicyCookie management for this domainTerms of Service Contact us

Search companies and directors from

Worldwide UK Gibraltar Luxembourg Spain Netherlands Curaçao Panama Malta Cayman Islands British Virgin Islands VenezuelaBermudaMexicoCosta Rica
Member of the Association of Independent Information Professionals A member company of the Spanish Multisectoral Information Association A member company of the Spanish Consumption Arbitration System, with code 413
Dato Capital Twitter
©2007-2024 DATO CAPITAL LTD United Kingdom (London WC2H 9JQ)
Cookie Policy We use cookies (including third party cookies) to improve navigation. Continuing browsing you consent to receive them. More information in our Cookie policy